InvestorsHub Logo
Followers 229
Posts 22046
Boards Moderated 4
Alias Born 09/16/2011

Re: None

Friday, 02/05/2016 2:52:42 PM

Friday, February 05, 2016 2:52:42 PM

Post# of 42458
Ok..in this sea of red I was able to find one bright stock.

IMMU $2.268 +0.4476 (+24.59%)

Released news today:
U.S. Food and Drug Administration (FDA) Grants Breakthrough Therapy Designation to Immunomedics for Sacituzumab Govitecan for the Treatment of Patients With Triple-Negative Breast Cancer
9:28 AM ET 2/5/16 | GlobeNewswire
Immunomedics, Inc., (Nasdaq:IMMU) today announced that its lead investigational antibody-drug conjugate, sacituzumab govitecan, or IMMU-132, has received Breakthrough Therapy Designation from the FDA for the treatment of patients with triple-negative breast cancer (TNBC) who have failed at least 2 prior therapies for metastatic disease.

The Breakthrough Therapy Designation was supported by a Phase 2 study in patients with metastatic TNBC who had received a median of 5 prior therapies (range, 2 - 12).

Here's the Daily Chart from StockCharts:


And Here's My Chart...150 Daily Candlesticks


IS THAT A HEAD AND SHOULDERS FORMING I SEE???
WHAT'S THE PLAY HERE???

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.